Oregon Health & Science University, Portland, OR, USA.
Am J Surg. 2013 May;205(5):602-7; discussion 607. doi: 10.1016/j.amjsurg.2013.01.026.
Currently, >200 meshes are commercially available in the United States. To help guide appropriate mesh selection, the investigators examined the postsurgical experiences of all patients undergoing ventral hernia repair at their facility from 2008 to 2011 with ≥12 months of follow-up.
A retrospective review of prospectively collected data was conducted. All returns (surgical readmission, office or emergency visit) for complications or recurrences were examined. The impact of demographics (age, gender, and body mass index [BMI]), risk factors (hernia grade, hernia size, concurrent and past bariatric surgery, concurrent and past organ transplantation, any concurrent surgery, and American Society of Anesthesiologists score), and prosthetic type (polypropylene, other synthetic, human acellular dermal matrix, non-cross-linked porcine-derived acellular dermal matrix, other biologic, or none) on the frequency of return was evaluated.
A total of 564 patients had 12 months of follow-up, and 417 patients had 18 months of follow-up. In a univariate regression analysis, study arm (biologic, synthetic, or primary repair), hernia grade, hernia size, past bariatric surgery, and American Society of Anesthesiologists score were significant predictors of recurrence (P < .05). Multivariate analysis, stepwise regression, and interaction tests identified three variables with significant predictive power: hernia grade, hernia size, and BMI. The adjusted odds ratios vs hernia grade 2 for surgical readmission were 2.6 (95% confidence interval [CI], 1.3 to 5.1) for grade 3 and 2.6 (95% CI, 1.1 to 6.4) for grade 4 at 12 months and 2.3 (95% CI, 1.1 to 4.6) for grade 3 and 4.2 (95% CI, 1.7 to 10.0) for grade 4 at 18 months. Large hernia size (adjusted odds ratio vs small size, 3.2; 95% CI, 1.6 to 6.2) and higher BMI (adjusted odds ratio for BMI ≥50 vs 30 to 34.99 kg/m(2), 5.7; 95% CI, 1.2 to 26.2) increased the likelihood of surgical readmission within 12 months.
The present data support the hypothesis that careful matching of patient characteristics to choice of prosthetic will minimize complications, readmissions, and the number of postoperative office visits.
目前,美国市场上有超过 200 种网片。为了帮助指导合适的网片选择,研究人员回顾性分析了 2008 年至 2011 年在他们的机构接受腹疝修补术的所有患者的术后经历,这些患者均接受了至少 12 个月的随访。
对前瞻性收集的数据进行回顾性分析。所有与并发症或复发相关的返回(手术再入院、门诊或急诊就诊)都进行了检查。评估了人口统计学因素(年龄、性别和体重指数[BMI])、危险因素(疝等级、疝大小、同期和既往减重手术、同期和既往器官移植、任何同期手术以及美国麻醉医师协会评分)和假体类型(聚丙烯、其他合成材料、人脱细胞真皮基质、非交联猪源性脱细胞真皮基质、其他生物材料或无)对返回频率的影响。
共有 564 例患者获得 12 个月的随访,417 例患者获得 18 个月的随访。在单变量回归分析中,研究组(生物、合成或原发性修复)、疝等级、疝大小、既往减重手术和美国麻醉医师协会评分是复发的显著预测因子(P<.05)。多变量分析、逐步回归和交互测试确定了三个具有显著预测能力的变量:疝等级、疝大小和 BMI。与疝等级 2 相比,疝等级 3 和 4 的手术再入院调整后比值比分别为 2.6(95%置信区间[CI],1.3 至 5.1)和 2.6(95%CI,1.1 至 6.4),在 12 个月时分别为 2.3(95%CI,1.1 至 4.6)和 4.2(95%CI,1.7 至 10.0)。疝体积较大(与体积较小相比,调整后比值比为 3.2;95%CI,1.6 至 6.2)和 BMI 较高(与 BMI 为 30 至 34.99kg/m2 相比,调整后比值比为 5.7;95%CI,1.2 至 26.2)会增加 12 个月内手术再入院的可能性。
本研究数据支持这样一种假设,即仔细匹配患者特征和假体选择将最大限度地减少并发症、再入院和术后门诊就诊的次数。